AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed'

CNBC reports that pharmaceutical giants AstraZeneca and Bristol Myers Squibb have spent months discussing a potential merger. The reports sent AstraZeneca shares lower, with analysts reportedly puzzled by the proposed deal.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton